{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:39:27Z","timestamp":1768448367785,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["60(0079)\/07\/EMR-II"],"award-info":[{"award-number":["60(0079)\/07\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00277-018-3249-1","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T03:10:15Z","timestamp":1518837015000},"page":"893-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hydroxyurea responses in clinically varied beta, HbE-beta thalassaemia and sickle cell anaemia patients of Eastern India"],"prefix":"10.1007","volume":"97","author":[{"given":"Tridip","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudipa","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"issue":"4","key":"3249_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<221::AID-AJH4>3.0.CO;2-R","volume":"62","author":"C Hoppe","year":"1999","unstructured":"Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L (1999) Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol 62(4):221\u2013227. https:\/\/doi.org\/10.1002\/(SICI)1096-8652(199912)62:4<221::AID-AJH4>3.0.CO;2-R","journal-title":"Am J Hematol"},{"key":"3249_CR2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood.V81.6.1630.1630","volume":"81","author":"E Fibach","year":"1993","unstructured":"Fibach E, Burke LP, Schechter AN, Noguchi CT, Rodgers GP (1993) Hydroxyurea Increases Fetal Hemoglobin in Cultured Erythroid Cells Derived From Normal Individuals and Patients With Sickle Cell Anemia or beta-thalassemia. Blood 81:1630\u20131635","journal-title":"Blood"},{"issue":"4","key":"3249_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","volume":"102","author":"M Bradai","year":"2003","unstructured":"Bradai M, Abad MT, Pissard S, Lamraoui F, Skopinski L, de Montalembert M (2003) Hydroxyurea can eliminate transfusion requirements in children with severe-thalassemia. Blood 102(4):1529\u20131530. https:\/\/doi.org\/10.1182\/blood-2003-01-0117","journal-title":"Blood"},{"key":"3249_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00277-005-1026-4","volume":"84","author":"A Dixit","year":"2005","unstructured":"Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP (2005) Hydroxyurea in thalassemia intermedia\u2014a promising therapy. Ann Hematol 84:441\u2013446","journal-title":"Ann Hematol"},{"issue":"3","key":"3249_CR5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.V87.3.887.bloodjournal873887","volume":"87","author":"S Fucharoen","year":"1996","unstructured":"Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP (1996) Hydroxyurea Increases Hemoglobin F Levels and Improves the Effectiveness of Erythropoiesis in beta-Thalassemia\/Hemoglobin E disease. Blood 87(3):887\u2013888","journal-title":"Blood"},{"issue":"231\u2013239","key":"3249_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1172\/JCI200316672","volume":"111","author":"VP Cokic","year":"2003","unstructured":"Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT, Schechter AN (2003) Hydroxyurea induces fetal hemoglobin by the nitric oxide\u2013dependent activation of soluble guanylyl cyclase. J Clin Investig 111(231\u2013239):231\u2013239. https:\/\/doi.org\/10.1172\/JCI200316672","journal-title":"J Clin Investig"},{"key":"3249_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00277-005-0049-1","volume":"85","author":"R Watanapokasin","year":"2006","unstructured":"Watanapokasin R, Sanmund D, Winichagoon P, Muta K, Fucharoen S (2006) Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia\/HbE patients\u2019 peripheral blood erythroid cell culture. Ann Hematol 85:164\u2013169","journal-title":"Ann Hematol"},{"issue":"5","key":"3249_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ajh.21120","volume":"83","author":"A Koren","year":"2008","unstructured":"Koren A, Levin C, Dgany O, Kransnov T, Elhasid R, Zalman L, Palmor H, Tamary H (2008) Response to hydroxyurea therapy in beta-thalassemia. Am J Hematol 83(5):366\u2013370. https:\/\/doi.org\/10.1002\/ajh.21120","journal-title":"Am J Hematol"},{"key":"3249_CR9","first-page":"352","volume":"77","author":"K Konstantopoulos","year":"1992","unstructured":"Konstantopoulos K, Vagiopoulos G, Kantouni R et al (1992) A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea? Haematologica 77:352\u2013354","journal-title":"Haematologica"},{"key":"3249_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1046\/j.1365-2141.1998.00719.x","volume":"101","author":"BR Saxon","year":"1998","unstructured":"Saxon BR, Rees D, Olivieri NF (1998) Regression of extramedullary haemopoiesis and augmentation of fetal hemoglobin concentration during hydroxyurea therapy in beta thalassemia. Br J Haematol 101:416\u2013419","journal-title":"Br J Haematol"},{"key":"3249_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00277-002-0501-4","volume":"81","author":"M Wegener","year":"2002","unstructured":"Wegener M, Debatin KM, Kohne E (2002) Treatment with hydroxyurea in thalassaemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis. Ann Hematol 81:478\u2013482","journal-title":"Ann Hematol"},{"issue":"Suppl 2","key":"3249_CR12","first-page":"316","volume":"2","author":"MR Gamberini","year":"2004","unstructured":"Gamberini MR, Fortini M, De Sanctis V (2004) Paraplegia due to spinal cord compression by extramedullary erythropoietic tissue in a thalassemia intermedia patient with gynecomastia secondary to cirrhosis: Successful treatment with Hydroxyurea. Pediatr Endocrinol Rev 2(Suppl 2):316\u2013318","journal-title":"Pediatr Endocrinol Rev"},{"key":"3249_CR13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood.V87.3.887.bloodjournal873887","volume":"87","author":"S Fucharoen","year":"1996","unstructured":"Fucharoen S, Siritanaratkul N, Winichagoon P et al (1996) Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia\/hemoglobin E disease. Blood 87:887\u2013892","journal-title":"Blood"},{"issue":"3","key":"3249_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1365-2141.2005.05768.x","volume":"131","author":"ST Singer","year":"2005","unstructured":"Singer ST, Kuypers FA, Olivieri NF, E\/b Thalassemia Study Group et al (2005) Fetal hemoglobin augmentation in E\/b(0) thalassemia: clinical and haematological outcome. Br J Haematol 131(3):378\u2013388. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05768.x","journal-title":"Br J Haematol"},{"key":"3249_CR15","first-page":"1172","volume":"89","author":"M Yavarian","year":"2004","unstructured":"Yavarian M, Karimi M, Bakker E et al (2004) Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. Haematologica 89:1172\u20131178","journal-title":"Haematologica"},{"key":"3249_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s00277-003-0836-5","volume":"83","author":"M Alebouyeh","year":"2004","unstructured":"Alebouyeh M, Moussavi F, Haddad-Deylami H et al (2004) Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening. Ann Haematol 83:430\u2013433","journal-title":"Ann Haematol"},{"issue":"7","key":"3249_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/01.mph.0000174386.13109.28","volume":"27","author":"M Karimi","year":"2005","unstructured":"Karimi M, Darzi H, Yavarian M (2005) Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. Pediatr Hematol Oncol 27(7):380\u2013385. https:\/\/doi.org\/10.1097\/01.mph.0000174386.13109.28","journal-title":"Pediatr Hematol Oncol"},{"key":"3249_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/10245330400020439","volume":"10","author":"I Panigrahi","year":"2005","unstructured":"Panigrahi I, Dixit A, Arora S et al (2005) Do a-deletions influence hydroxyurea response in thalassemia intermedia. Hematology 10:61\u201363","journal-title":"Hematology"},{"issue":"4","key":"3249_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3109\/03630269.2014.927770","volume":"38","author":"M Kosaryan","year":"2014","unstructured":"Kosaryan M, Zafari M, Alipur A, Hedayatizadeh-Omran A (2014) The effect and side effect of hydroxyurea therapy on patients with beta-thalassemia: a systematic review to December 2012. Hemoglobin 38(4):262\u2013271. https:\/\/doi.org\/10.3109\/03630269.2014.927770","journal-title":"Hemoglobin"},{"issue":"6","key":"3249_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/03630269.2015.1068799","volume":"39","author":"T Chatterjee","year":"2015","unstructured":"Chatterjee T, Chakravarty A, Chakravarty S (2015) Population screening and prevention strategies for thalassemias and other hemoglobinopathies of Eastern India: experience of 18,166 cases. Hemoglobin 39(6):384\u2013388. https:\/\/doi.org\/10.3109\/03630269.2015.1068799","journal-title":"Hemoglobin"},{"issue":"6","key":"3249_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/03630269.2014.977448","volume":"38","author":"T Chatterjee","year":"2014","unstructured":"Chatterjee T, Chakravarty A, Chakravarty S (2014) Mutational spectrum of thalassemias and other hemoglobinopathies in West Bengal, Eastern India. Hemoglobin 38(6):405\u2013408. https:\/\/doi.org\/10.3109\/03630269.2014.977448","journal-title":"Hemoglobin"},{"key":"3249_CR22","first-page":"77","volume":"9","author":"JM Old","year":"1991","unstructured":"Old JM (1991) Methods in Molecular Biology; Protocols in Human Molecular Genetics; Detection of Mutations by the Amplification Refractory Mutation System (ARMS) 9:77\u201384","journal-title":"Protocols in Human Molecular Genetics; Detection of Mutations by the Amplification Refractory Mutation System (ARMS)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3249-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3249-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T07:27:26Z","timestamp":1603870046000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3249-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3249"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3249-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"10 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}